By Canadian Press

Canada-China COVID-19 vaccine trials abandoned: National Research Council

Aug 27, 2020 | 1:07 PM

HALIFAX — A COVID-19 vaccine-development partnership between China’s CanSino Biologics and Dalhousie University in Nova Scotia has been abandoned.

The National Research Council of Canada said today in a statement the CanSino vaccine intended for phase one clinical trials has not been approved by Chinese customs for shipment to Canada.

Because of that delay the NRC says the opportunity to conduct the trials is over.

The NRC says the Canadian Center for Vaccinology had been ready to start clinical trials as early as June, after Health Canada approved CanSino’s proposal.

The Halifax lab was one of several in Canada and in the U.S. whose work in 2014 led to an Ebola vaccine that was used in West Africa.

Meaningful Mementos

Remembering Someone You've Lost at Christmas

Dec 03, 2024

Seasonal Sorrow

How Do You Get Through The Holidays When You're Grieving?

Nov 01, 2024

Upcoming Events at Oliver's

Grief & Loss and Estate Planning Seminars

Oct 02, 2024

In its statement, the NRC says it will focus on other partners and other COVID-19 priorities.

This report by The Canadian Press was first published Aug. 27, 2020.

The Canadian Press